 Bloomberg [1] |
Teva Pursues First Type 1 Diabetes Treatment Since Insulin [2]
BusinessWeek Diamyd Medical AB terminated an agreement with a Johnson & Johnson unit to develop a Type 1 diabetes treatment [3] in June after the medicine failed to preserve beta cell function after 15 months, the primary goal in a late-stage trial. … Teva nearing post-insulin diabetes therapy [4]Globes Teva looks to revolutionize Type 1 diabetes therapy with Sanofi cast-off … [5]FiercePharma all 7 news articles » [6] |
More details can be found at www.diabeteshowto.com [7]